INTRODUCTION
Acquired immunodeficiency syndrome (AIDS) is mainly caused by human immunodeficiency virus type 1 (HIV-1) infection and remains one of the biggest medical barriers for human health, since it was first reported in 1981 (Gottlieb et al., 1981) . The reverse transcriptase (RT) of the HIV-1 plays a significant role in the viral replication process, which makes it a pivotal target for anti-HIV-1 inhibitor discovery (Jonckheere, Anné, De Clercq, 2000; Yisma et al., 2014) . Although numerous RT inhibitors, including primarily the nucleoside/ nucleotide RT inhibitors (NRTIs), e.g., zidovudine, and non-nucleoside RT inhibitors (NNRTIs), e.g., nevirapine, delavirdine and efavirenz, have been developed, like other anti-HIV inhibitors, effectiveness of now approved NRTIs and NNRTIs have been hampered because of the fast development of resistance (Boone, 2006; De Clercq, 2002; Sluis-Cremer, Wainberg, Schinazi, 2015; Yu et al., 2011) . It is estimated that 36.9 million people (including 2.6 million children) were living with HIV infection in the year 2014 according to UNAIDS-2015 report, and 1.2 million people died due to HIV as well as related diseases (Chander et al., 2016) . To circumvent this challenge, there is an urgent need to discover and develop safe, green, efficient, selective and novel anti-HIV inhibitors having significant potency against drugresistant RT viral strains as well as less toxicity (Chander et al., 2016; Huang et al., 2007; Polanski et al., 2006; Safakish et al., 2017) .
Hydrazones are excellent candidates for the research of antiprotozoal agents (Carvalho et al., 2014; de Sá Alves, Barreiro, Fraga, 2009 ), multidentate ligands (Bessy Raj, Prathapachandra Kurup, Suresh, 2008 , pesticidal agents (Che et al., 2013b; Guo et al., 2012) and gelatinase inhibitors . Meanwhile, N-arylsulfonylindoles or N-arylsulfonyl-3-acylindoles are excellent candidates for the study of anti-HIV-1 inhibitors (Che et al., 2016; Fan et al., 2009; Ran et al., 2010) , and especially some N-arylsulfonyl-3-acetylindoles showed potent anti-HIV-1 activity. Nevertheless, the anti-HIV-1 activity of the N-arylsulfonyl-3-acylindole benzoyl Page 2 / 7 hydrazones has not been previously published. Inspired by these previous observations, and the goal in this program is to discover new compounds with potent biological activity (Che et al., 2013a; Che et al., 2015; Che et al., 2016; Xu, Che, Wang, 2011) , we report here the results of the anti-HIV-1 activity of 32 N-arylsulfonyl-3-acylindole benzoyl hydrazone derivatives for the first time.
RESULTS AND DISCUSSION

Chemistry
32 N-Arylsulfonyl-3-acylindole benzoyl hydrazone analogs (1-32, Figure 2) were smoothly synthesized as shown in Scheme 1. N-Arylsulfonyl-3-acetylindoles (A) reacted with the corresponding benzoyl hydrazides (B) in the presence of AcOH at reflux, and compounds 1-32 were prepared, as well as characterized by satisfactory proton nuclear magnetic resonance ( 1 H NMR), carbon nuclear magnetic resonance ( 13 C NMR), electrospray ion trap mass spectrometry (ESI-TRAP-MS), high-resolution mass spectra (HR-MS), as well as melting point (Che et al., 2013b) . Owing to the steric hindrance, the substituents on the C-N bond of all compounds adopted a trans configuration (E configuration) (Carvalho et al., 2014; Che et al., 2013b; Lourenço et al., 2008) .
Interestingly, all reactants dissolved well in anhydrous ethanol in the beginning of the reaction. As the reaction progressed, some insoluble species were gradually precipitated out, as well as at the end of the reaction, a large amount of solid accumulated in the bottom of the flask. As a result of this behavior, all the desired N-arylsulfonyl-3-acylindole benzoyl hydrazone analogs (1-32) could be obtained by filtration. This procedure imbues the synthetic methodology with green credentials.
Moreover, target compounds 1-32 were analysed by reverse phase high-performance liquid chromatography (RP-HPLC), and all compounds purity were >95%.
Biological activities
As our ongoing work on research of anti-HIV-1 inhibitors, purified and characterized N-arylsulfonyl-3-acylindole benzoyl hydrazones 1-32 were screened in vitro for their inhibitory activity against HIV-1 replication in acutely infected C8166 cells, and 3′-azido-3′-deoxythymidine (AZT) was used as a positive control presented in Table I .
The results of anti-HIV-1 viral replication assay revealed that, out of thirty-two evaluated compounds, two (18 and 23) showed significant anti-HIV-1 activity ( In order to elucidate the anti-HIV-1 activity of compounds 1-32 at a molecular basis and to reveal structural features critical for their anti-HIV-1 activity, a brief investigation of structure activity relationship (SAR) was determined, which revealed how the substituents on 1-32 were related to the anti-HIV-1 activity. In general, (1) R 3 = Me was more vital for the anti-HIV-1 activities than R 3 = H, Et, or n-pentyl. 
respectively). (3) R
2 as the 3-nitro group also plays an important role in the activities against the HIV viral replication. For example, when R 3 = H and R 1 = 6-Me, the corresponding compound 10 usually displayed more potent anti-HIV-1 activity (TI = 116.23); When R 3 = Me and R 1 = H or 6-Me, the corresponding compounds 18 and 23 also exhibited the most remarkable anti-HIV-1 activity (TI >769.23 and >645.16, respectively). (4) It is noteworthy that introduction of R 3 as the methyl group and R 2 as the hydrogen group could result in more potent compounds. For example, the EC 50 and TI values of compounds 14, 19, 24 and 27 were 0.52, 0.49, 0.67, 0.50 μg/mL, and >384.61, >408.16, >298.50, 249.86, respectively. This suggested that introduction of R 3 as the methyl group could be taken into account for further preparation of these kinds of compounds as anti-HIV-1 agents.
EXPERIMENTAL SECTION Compound purity assessment
The purity of N-arylsulfonyl-3-acylindole benzoyl hydrazone derivatives 1-32 were recorded on a Shimadzu LC-15C liquid chromatograph [SPD-15C UV-vis spectrophotometric detector (190-700 nm)] using a flow rate of 1.0 mL/min (MeOH/H 2 O = 5/1) and a Hypersil ODS C 18 column (5 μm, 4.6 × 150 mm) as the stationary phase, and all compounds purity were >95%.
Anti-HIV-1 activity assay
Cells and virus
The cell line (C8166) and the laboratory-derived virus (HIV-1 IIIB ) were obtained from the Medical Research Council, AIDS Reagent Project, London, UK. C8166 was maintainedin RPMI-1640 medium supplemented with 10% heat-inactivated newborn calf serum (Gibco, Grand Island, NY, USA). The cells used in all experiments were in log-phasegrowth. The 50% HIV-1 IIIB tissue culture infectious dose (TCID 50 ) in C8166 cells was determined and calculated by the Reed and Muench method. Virusstocks were stored in small aliquots at -70 o C.
MTT-based cytotoxicity assay
Cellular toxicity of compounds 1-32 on C8166 cells was assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) method as described previously. Briefly, cells were seeded in a 96-well microtiter plate in the absence or presence of various concentrations of compounds in triplicate and incubated at 37 o C in a humid atmosphere of 5% CO 2 for 3 days. The supernatants were discarded and MTT reagent (5 mg/mL in PBS) was added to each well, then incubated for 4 h, after which 100 μL of 50% DMF-20% SDS was added. After the formazan was dissolved completely, the plates were read on a BioTekElx800 ELISA reader (BioTek, Winooski, VT, USA) at 595/630 nm. Thecytotoxic concentration that caused the reduction of viable C8166cells by 50% (CC 50 ) was determined from the dose-response curve.
Syncytia assay
In the presence of 100 μL of various concentrations of compounds 1-32, C8166 cells (4×10 5 /mL) were infected with HIV-1 IIIB at a multiplicity of infection (M.O.I) of 0.06. The final volume per well was 200 μL. Control assays were performed without the test compounds in HIV-1 IIIB infected and uninfected cultures. After 3 days of culture, the cytopathic effect (CPE) was measured by counting the number of syncytia. Percentage inhibition of syncytia formationwas calculated, and the 50% effective concentration (EC 50 ) was calculated. 3′-Azido-3′-deoxythymidine (AZT; Sigma-Aldrich, St. Louis, MO, USA) was used as a positive control. The therapeutic index (TI) was calculated as CC 50 /EC 50 .
CONCLUSIONS
In the present study, 32 N-arylsulfonyl-3-acylindole benzoyl hydrazone derivatives were prepared and screened in vitro as HIV-1 inhibitors for the first time.
Among the reported analogues, compounds 10, 14, 18-20, 23, 24 and 27 exhibited significant anti-HIV-1 activity with EC 50 values of 1. 02, 0.52, 0.26, 0.49, 1.65, 0.31, 0.67 and 0.50 μg/mL, and TI values of 116.33, >384.61, >769.23, >408.16, >121.21, >645.16, >298.50 and >249.86, phenylsulfonyl-3-acetylindole benzoyl hydrazone (18) and N-(3-nitro)phenylsulfonyl-3-acetyl-6-methylindole benzoyl hydrazone (23) displayed the highest anti-HIV-1 activity.
